Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
ONESOURCE

OneSource Specialty Pharma Share Price

 
Stock Result Declared

 

OneSource Specialty Pharma live price: ₹1819.9. It opened at ₹1,761 vs previous close ₹1,790; intraday high/low: ₹1,850/₹1,760. The 50 & 200 DMA stand at ₹1,596.22/₹1,602.08.

OneSource Specialty Pharma Performance

  • Today's Low
  • ₹1,760
  • Today's High
  • ₹1,850
  • 52 Week Low
  • ₹1,057
  • 52 Week High
  • ₹2,248
  • Open Price₹1,761
  • Previous Close₹1,790
  • Volume283,056
  • 50 DMA₹1,596.22
  • 100 DMA₹1,571.66
  • 200 DMA₹1,602.08

OneSource Specialty Pharma Chart

Investment Returns

  • Over 1 Month + 17.79%
  • Over 3 Month + 53.55%
  • Over 6 Month + 5.44%
  • Over 1 Year + 10.37%

Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!

Invest Now

OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -282.7
  • PEG Ratio
  • 0.9
  • Market Cap Cr
  • 20,864
  • P/B Ratio
  • 3.6
  • Average True Range
  • 82.88
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 88.14
  • RSI
  • 62.8
  • MFI
  • 85.02

OneSource Specialty Pharma Financials

OneSource Specialty Pharma Technicals

EMA & SMA

Current Price
₹1,819.90
+ 30.1 (1.68%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,714.16
  • 50 Day
  • ₹1,596.22
  • 100 Day
  • ₹1,571.66
  • 200 Day
  • ₹1,602.08

Resistance and Support

1785.27 Pivot Speed
  • R3 1,943.53
  • R2 1,889.27
  • R1 1,839.53
  • S1 1,735.53
  • S2 1,681.27
  • S3 1,631.53

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

India’s first specialty pharma CDMO offers drug-device combinations, complex injectables, biologics, and soft gelatin capsules. Operating across multiple technology platforms, its 1,200+ professionals deliver tailored solutions for drug development and manufacturing with agility and expertise.

Onesource Specialty Pharma Ltd has an operating revenue of Rs. 1,419.33 Cr. on a trailing 12-month basis. An annual revenue growth of 730% is outstanding, Pre-tax margin of -5% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 19% and 9% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 55 which is a POOR score indicating inconsistency in earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 67 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-13 Audited Results
2026-01-23 Quarterly Results
2025-11-11 Quarterly Results
2025-08-04 Quarterly Results
2025-05-05 Audited Results

OneSource Specialty Pharma Shareholding Pattern

30.48%
10.13%
3.35%
17.5%
0%
12.18%
26.36%

OneSource Specialty Pharma FAQs

OneSource Specialty Pharma share price is ₹1,819 As on 14 May, 2026 | 15:38

The Market Cap of OneSource Specialty Pharma is ₹20863.8 Cr As on 14 May, 2026 | 15:38

The P/E ratio of OneSource Specialty Pharma is -282.7 As on 14 May, 2026 | 15:38

The PB ratio of OneSource Specialty Pharma is 3.6 As on 14 May, 2026 | 15:38

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23